Antibodies

06 Oct 2008 Novo Nordisk and Innate Pharma swap product rights
05 Oct 2008 Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
05 Oct 2008 Genentech, Glycart and Roche enter into collaboration agreement for potential cancer therapy
02 Oct 2008 Progenics Announces Progress and Presentations in HIV Therapy Program
02 Oct 2008 Crucell Announces Positive Results of Phase II Clinical Study Rabies Monoclonal Antibody Combination in US
02 Oct 2008 Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
02 Oct 2008 Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody
02 Oct 2008 Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation
30 Sep 2008 Antisoma starts phase II trial of AS1402 in breast cancer
30 Sep 2008 Phase 2 Study of IMC-1121B for Advanced Ovarian Cancer Commences Patient Enrollment
29 Sep 2008 VEGF Trap-Eye Final Phase 2 Results in Age-related Macular Degeneration Presented at 2008 Retina Society Meeting
25 Sep 2008 Randomized Phase 2 Study of IMC-A12 for Advanced Breast Cancer Commences Patient Enrollment
24 Sep 2008 PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
23 Sep 2008 AVEO Initiates First Clinical Trial of Novel HGF Antagonist
23 Sep 2008 ERBITUX(R) Five-Year Data Show Significant Improvement in Overall Survival for Patients with Locally or Regionally Advanced Head and Neck Cancer
22 Sep 2008 Maxygen and Astellas Announce Global Agreement to Develop New Therapies for Autoimmune Diseases and Transplantation
22 Sep 2008 Recruitment Completed In Ofatumumab NHL Front Line Study
22 Sep 2008 Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease
21 Sep 2008 FDA issues complete response letter to Roche for Actemra Biologics License Application
21 Sep 2008 Findings from Landmark Study show Ustekinumab Demonstrated Superior Efficacy to Enbrel(R) (Etanercept) in Treatment of Moderate to Severe Plaque Psoriasis
17 Sep 2008 Bio3 Research S.r.l. and ProtElix Inc. enter into an agreement for the development of mimic-antibody HMGB1 antagonists to prevent restenosis and atherosclerotic plaque progression
17 Sep 2008 InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
16 Sep 2008 Denosumab Osteoporosis Trial Finds Patients Transitioned from Alendronate (Fosamax(R)) to Denosumab Achieved Significantly Greater Gains in Bone Mineral Density versus Those Continuing on Alendronate
16 Sep 2008 Merck KGaA: New First-Line Data Demonstrate Response Rates of Up to 80% for Erbitux in KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)
16 Sep 2008 New data confirms Avastin as the only biologic to demonstrate overall survival when used first-line in metastatic colorectal cancer patients with K-RAS (wild-type) gene status

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top